Royal Bank of Canada’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57K | Sell |
3,563
-18
| -0.5% | -$288 | ﹤0.01% | 5502 |
|
|
2025
Q1 | $61K | Sell |
3,581
-1,038
| -22% | -$17.7K | ﹤0.01% | 5124 |
|
|
2024
Q4 | $114K | Sell |
4,619
-5,064
| -52% | -$125K | ﹤0.01% | 4800 |
|
|
2024
Q3 | $276K | Sell |
9,683
-10,659
| -52% | -$304K | ﹤0.01% | 4141 |
|
|
2024
Q2 | $537K | Buy |
20,342
+1,845
| +10% | +$48.7K | ﹤0.01% | 3602 |
|
|
2024
Q1 | $597K | Sell |
18,497
-21,239
| -53% | -$685K | ﹤0.01% | 3449 |
|
|
2023
Q4 | $1.67M | Sell |
39,736
-305
| -0.8% | -$12.8K | ﹤0.01% | 2771 |
|
|
2023
Q3 | $1.54M | Buy |
40,041
+35,692
| +821% | +$1.37M | ﹤0.01% | 2682 |
|
|
2023
Q2 | $83K | Buy |
4,349
+470
| +12% | +$8.97K | ﹤0.01% | 5027 |
|
|
2023
Q1 | $60K | Sell |
3,879
-2,297
| -37% | -$35.5K | ﹤0.01% | 5145 |
|
|
2022
Q4 | $109K | Buy |
6,176
+4,635
| +301% | +$81.8K | ﹤0.01% | 4922 |
|
|
2022
Q3 | $9K | Buy |
1,541
+275
| +22% | +$1.61K | ﹤0.01% | 5984 |
|
|
2022
Q2 | $5K | Sell |
1,266
-2,267
| -64% | -$8.95K | ﹤0.01% | 6178 |
|
|
2022
Q1 | $20K | Sell |
3,533
-5,093
| -59% | -$28.8K | ﹤0.01% | 6118 |
|
|
2021
Q4 | $74K | Buy |
8,626
+4,228
| +96% | +$36.3K | ﹤0.01% | 5609 |
|
|
2021
Q3 | $38K | Buy |
4,398
+1,289
| +41% | +$11.1K | ﹤0.01% | 5800 |
|
|
2021
Q2 | $33K | Buy |
3,109
+758
| +32% | +$8.05K | ﹤0.01% | 5793 |
|
|
2021
Q1 | $38K | Buy |
2,351
+316
| +16% | +$5.11K | ﹤0.01% | 5561 |
|
|
2020
Q4 | $94K | Buy |
2,035
+344
| +20% | +$15.9K | ﹤0.01% | 4837 |
|
|
2020
Q3 | $60K | Buy |
1,691
+1,649
| +3,926% | +$58.5K | ﹤0.01% | 4788 |
|
|
2020
Q2 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 5952 |
|